Hydramine and Cefaclor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydramine (diphenhydramine hydrochloride) and Cefaclor (cefaclor). Common drug interactions include parotitis among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Hydramine and Cefaclor. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Cefaclor?

Cefaclor has active ingredients of cefaclor. eHealthMe is studying from 2,512 Cefaclor users. Check the latest studies of Cefaclor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

59 people who take Hydramine and Cefaclor together, and have interactions are studied.

Hydramine and Cefaclor drug interactions.

What are the common drug interactions of Hydramine and Cefaclor, by gender? *:

female:

  1. Parotitis (inflammation of a parotid gland)
  2. Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)
  3. Renal impairment (severely reduced kidney function)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Injection site pain
  6. Ligament sprain (ligament stretched)
  7. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  8. Renal failure (kidney dysfunction)
  9. Respiratory tract infection
  10. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)

male:

  1. White blood cell count decreased
  2. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  3. Diarrhoea
  4. Anaemia (lack of blood)
  5. Constipation
  6. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  7. Infusion related reaction
  8. Pyrexia (fever)
  9. Urinary tract infection
  10. Blood urine present

What are the common drug interactions of Hydramine and Cefaclor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Skeletal injury (bone and supporting muscle injury)
  2. Sleep talking (talking during sleeping)
  3. Somnambulism (sleep walking)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Tendon injury
  6. Tendonitis (a condition that causes pain and swelling of tendons)
  7. Weight increased
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Cellulitis (infection under the skin)
  10. Chest pain

50-59:

  1. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  2. Platelet count decreased
  3. White blood cell count decreased
  4. Anaemia (lack of blood)
  5. Hypokalaemia (low potassium)
  6. Hypoproteinaemia (too little prolactin circulating in the blood)
  7. Haematuria (presence of blood in urine)
  8. Hydronephrosis (water inside the kidney)
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  10. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

60+:

  1. White blood cell count decreased
  2. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  3. Oedema peripheral (superficial swelling)
  4. Constipation
  5. Diarrhoea
  6. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  7. Infusion related reaction
  8. Nausea (feeling of having an urge to vomit)
  9. Pain
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Pain: 18 people, 30.51%
  2. Cough: 11 people, 18.64%
  3. High Blood Pressure: 11 people, 18.64%
  4. Urination - Excessive Volume: 9 people, 15.25%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 15.25%
  6. Urinary Tract Infection: 9 people, 15.25%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 13.56%
  8. Depression: 7 people, 11.86%
  9. Primary Immunodeficiency Syndrome: 7 people, 11.86%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 11.86%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and Cefaclor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydramine and Cefaclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefaclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydramine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefaclor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and cefaclor (the active ingredients of Hydramine and Cefaclor, respectively), and Hydramine and Cefaclor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: